drugset / Trial / NCT00370864

Study of a Pandemic Influenza Vaccine in Children

NCT00370864 ↗

Phase 2 Completed 220 enrolled Seqirus
RandomizedParallel-groupDouble-blindPrevention

Summary

The World Health Organisation has warned that an influenza pandemic is inevitable. The avian influenza strain H5N1 is one of the leading candidates to cause the next influenza pandemic. Children are likely to be a special target group for vaccination; therefore, this study will test the safety and immunogenicity of an H5N1 pandemic influenza vaccine in healthy children.

Timeline

Start
2006-09
Primary completion
—
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject H5N1 Pandemic Influenza Vaccine Vaccine 30 ug —
Subject H5N1 Pandemic Influenza Vaccine Vaccine 45 ug —

Indications